Fueling Open Innovation for Malaria Transmission-Blocking Drugs: Hundreds of Molecules Targeting Early Parasite Mosquito Stages

BACKGROUND: Despite recent successes at controlling malaria, progress has stalled with an estimated 219 million cases and 435,000 deaths in 2017 alone. Combined with emerging resistance to front line antimalarial therapies in Southeast Asia, there is an urgent need for new treatment options and nove...

Descripción completa

Detalles Bibliográficos
Autores principales: Delves, Michael, Lafuente-Monasterio, M. Jose, Upton, Leanna, Ruecker, Andrea, Leroy, Didier, Gamo, Francisco-Javier, Sinden, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753678/
https://www.ncbi.nlm.nih.gov/pubmed/31572339
http://dx.doi.org/10.3389/fmicb.2019.02134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753678/
https://www.ncbi.nlm.nih.gov/pubmed/31572339
http://dx.doi.org/10.3389/fmicb.2019.02134

Ejemplares similares